Effects of CreaSafe® on Kidney, Muscle, and Cardiopulmonary Function in Athletes and COPD Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
CopdAthletes
Interventions
DIETARY_SUPPLEMENT

CreaSafe® creatine

Will receive CreaSafe® creatine (0.03 g/kg/day) for 90 days, orally administered diluted in water, every morning (between 7:00 and 9:00 a.m.)

COMBINATION_PRODUCT

Placebo 0.03 g/kg/day

will receive a placebo (microcrystalline cellulose; 0.03 g/kg/day) for 90 days, orally administered diluted in water, every morning (between 7:00 and 9:00 a.m.)

Trial Locations (1)

75083-515

Evangelical University of Goiás, Anápolis

All Listed Sponsors
lead

Federal University of São Paulo

OTHER